Filters close
Newswise: Where do clots begin? McMaster researchers create device to replicate conditions in blood vessels after grafts
Released: 11-Aug-2022 11:30 AM EDT
Where do clots begin? McMaster researchers create device to replicate conditions in blood vessels after grafts
McMaster University

McMaster researchers create device to replicate conditions in blood vessels after grafts

Released: 2-Aug-2022 4:30 PM EDT
Crude and adjusted comparisons of cesarean delivery rates using the Robson classification
McMaster University

The authors conducted a population-based cohort study including 1,951,984 deliveries in Sweden and British Columbia, Canada, from 2004 to 2016, with data obtained from national and provincial birth registers. They assessed differences in caesarean delivery rates between countries and over time using the WHO-endorsed caesarean delivery classification. They compared these differences in caesarean delivery rates with and without accounting for population differences in maternal, fetal, and obstetric practice factors, such as maternal age, maternal body-mass-index, fetal weight and fetal position.

Newswise: One-two punch: Researchers discover sophisticated mechanism that bacteria use to resist antibiotics
26-Jul-2022 4:15 PM EDT
One-two punch: Researchers discover sophisticated mechanism that bacteria use to resist antibiotics
McMaster University

Researchers at Canada's McMaster University have discovered a significant and previously unknown mechanism that many bacteria use to resist antibiotics.

Newswise: Histamine-producing gut bacteria can trigger chronic abdominal pain
27-Jul-2022 1:05 PM EDT
Histamine-producing gut bacteria can trigger chronic abdominal pain
McMaster University

The McMaster-Queen’s research team pinpointed the bacterium Klebsiella aerogenes as the key histamine producer by studying germ-free mice colonized with gut microbiota from patients with IBS. They also colonized some mice with gut microbiota from healthy volunteers as a control group. The study found that the bacterium Klebsiella aerogenes converts dietary histidine, an essential amino acid present in animal and plant protein, into histamine, a known mediator of pain.

Released: 26-Jul-2022 4:05 PM EDT
Moderna vaccines better protect long-term care home residents
McMaster University

Moderna vaccines are better than Pfizer in protecting residents of long-term care (LTC) homes from COVID-19 Omicron infections, say McMaster University researchers.

Released: 20-Jul-2022 10:50 AM EDT
Adjusting diet has pros and cons for treating eczema, study says
McMaster University

People with mild or moderate eczema may gain some relief from their condition by adjusting their diets, but there are important downsides that make diets for eczema not a choice to take lightly, says McMaster University researcher Derek Chu.

Newswise: Iodine status varies across Canada, raising deficiency risk in some regions
Released: 11-Jul-2022 11:05 AM EDT
Iodine status varies across Canada, raising deficiency risk in some regions
McMaster University

Iodine deficiency, a public health concern resolved decades ago, may be making a comeback due to changing eating habits, according to new findings by McMaster University researchers.

Released: 5-Jul-2022 9:45 AM EDT
South Asian Communities in GTA disproportionately hit by COVID-19
McMaster University

A COVID CommUNITY – South Asian study, published in the Canadian Medical Association Journal (CMAJ) Open has found that South Asian communities living in the Greater Toronto Area (GTA) suffered disproportionately from COVID-19 in the first year of the pandemic.

Newswise: Caught in the act: Researchers find deadly fungus can multiply by having sex, which could produce more drug-resistant, virulent strains
Released: 27-Jun-2022 9:00 AM EDT
Caught in the act: Researchers find deadly fungus can multiply by having sex, which could produce more drug-resistant, virulent strains
McMaster University

Researchers at McMaster University have unlocked an evolutionary mystery of a deadly pathogen responsible for fueling the superbug crisis: it can reproduce by having sex.

Newswise: Researchers Find Medical Industry Funded Studies More Likely to Find New Treatments Cost Effective
21-Jun-2022 3:10 PM EDT
Researchers Find Medical Industry Funded Studies More Likely to Find New Treatments Cost Effective
McMaster University

New drugs and technologies covered by insurance plans can be much more profitable than those not covered, which may lead to bias in CEAs funded by pharmaceutical or other medical industry firms. The research team gleaned its data by analysing the results of more than 8,000 CEAs published between 1976 and March 2021. Nearly 30 per cent of these CEAs were sponsored by industry.

Newswise: Researchers Reconstruct the Genome of Centuries-Old E. coli Using Fragments Extracted From an Italian Mummy
15-Jun-2022 11:00 AM EDT
Researchers Reconstruct the Genome of Centuries-Old E. coli Using Fragments Extracted From an Italian Mummy
McMaster University

An international team led by researchers at McMaster University, working in collaboration with the University of Paris Cité, has identified and reconstructed the first ancient genome of E. coli, using fragments extracted from the gallstone of a 16th century mummy.

Newswise: Researchers Create Rapid Test for Deadly Infections in Livestock
Released: 10-Jun-2022 9:55 AM EDT
Researchers Create Rapid Test for Deadly Infections in Livestock
McMaster University

Researchers at McMaster University have developed a new form of rapid test to detect infections in farm animals, responding to the rising threat of dangerous outbreaks.

Newswise: Going all the way: Scientists prove that inhaled vaccines offer better protection and immunity than nasal sprays
9-Jun-2022 12:05 AM EDT
Going all the way: Scientists prove that inhaled vaccines offer better protection and immunity than nasal sprays
McMaster University

McMaster University scientists who compared respiratory vaccine-delivery systems have confirmed that inhaled aerosol vaccines provide far better protection and stronger immunity than nasal sprays.

Newswise: Older Persons with Type 1 Diabetes Face Risk of Reduced Muscle Strength and More Cardiovascular Issues, Researchers Find
Released: 9-Jun-2022 9:05 PM EDT
Older Persons with Type 1 Diabetes Face Risk of Reduced Muscle Strength and More Cardiovascular Issues, Researchers Find
McMaster University

Older adults with Type 1 diabetes (T1D) are at significantly higher risk of both muscle weakening and cardiovascular complications, say McMaster University researchers

Released: 8-Jun-2022 11:05 AM EDT
Rapid, Reliable Test for COVID and Other Infections, Created by McMaster Researchers, Moves Toward Marketplace
McMaster University

McMaster University researchers behind a new form of rapid, accurate and portable diagnostic test are moving their work toward the marketplace.

   
Newswise: Radiotherapy Not Always Needed for Early Breast Cancer
6-Jun-2022 10:20 AM EDT
Radiotherapy Not Always Needed for Early Breast Cancer
McMaster University

McMaster researchers tracked 501 patients with luminal A breast cancer for five years post-surgery and found the recurrence of cancer in the breast was just 2.3 per cent without radiotherapy. This was roughly comparable with a 1.9 per cent risk this patient sample had of developing a new breast cancer in their other untreated breast.

Released: 26-May-2022 1:05 PM EDT
Prone positioning may not be helpful for all awake hypoxemic COVID-19 patients
McMaster University

At the beginning of the COVID-19 pandemic, prone positioning was believed to be a potentially useful intervention – one that warranted further investigation. While some studies suggested awake prone positioning was safe, there was insufficient evidence to recommend using this strategy in clinical guidelines. COVI-PRONE, designed to provide robust evidence, included 21 hospitals in Canada, Saudi Arabia, Kuwait, and the United States. Researchers aimed to use prone positioning in hypoxemic COVID-19 patients for 8 to 10 hours per day, with 2 to 3 breaks, as needed. Participants in the control group were not proned and were asked not to position themselves in the prone position.

Released: 17-May-2022 2:30 PM EDT
Type-I interferon stops immune system ‘going rogue’ during viral infections
McMaster University

McMaster University researchers have discovered that Type I interferon (IFN) plays a key role in helping the immune system effectively target viruses, while stopping white blood cells from ‘going rogue’ and attacking the body’s own organs.

Newswise: Hidden benefit: Facemasks may reduce severity of COVID-19 and pressure on health systems, researchers find
3-May-2022 5:05 PM EDT
Hidden benefit: Facemasks may reduce severity of COVID-19 and pressure on health systems, researchers find
McMaster University

McMaster University researchers who study the dynamics of infectious disease transmission have investigated the population-level consequences of a potentially significant––and unobvious––benefit of wearing masks.

Newswise: New Cardiac Defibrillator Much Safer for Patients: Study
Released: 30-Apr-2022 9:00 AM EDT
New Cardiac Defibrillator Much Safer for Patients: Study
McMaster University

A study has demonstrated that a new type of cardiac defibrillator called a subcutaneous ICD (S-ICD) reduced patient complications by more than 90 percent, compared to the TV-ICD. The study involved 544 eligible patients (one-quarter females) with average age of 49, at 14 clinical centres in Canada

Newswise: Energy-burning brown fat less active in boys with obesity
Released: 14-Apr-2022 11:05 AM EDT
Energy-burning brown fat less active in boys with obesity
McMaster University

The researchers of McMaster’s Centre for Metabolism, Obesity and Diabetes Research performed MRI scans to measure BAT activity in 26 boys between the ages of eight and 10. They studied the BAT tissue in the neck before and after one hour of exposure to a cold suit set at a temperature of 18 degrees Celsius. The patient sample included 13 boys with a normal BMI and the same number again with obesity, in the first study of its kind in children.

Newswise: Regular cycling helps patients with ‘accelerated aging’ disease
Released: 11-Apr-2022 11:05 AM EDT
Regular cycling helps patients with ‘accelerated aging’ disease
McMaster University

Cycling for 35 minutes three times a week for 12 weeks led to a 32 per cent increase in overall fitness in people with MD. Patients who took part in the study also saw a 1.6-kilogram increase in their muscle mass and a two per cent reduction of body fat. They were also able to walk an extra 47 metres in six minutes, when tested by researchers at the end of the 12-week trial. Eleven patients took part in the study.

31-Mar-2022 4:20 PM EDT
Major bleeding reduced in patients having non-cardiac surgery
McMaster University

The drug tested, tranexamic acid (TXA), was given to patients at risk of bleeding or vascular complications. The study found that TXA did not increase deep vein clotting known as VTE, heart attack, non-hemorrhagic stroke, or other major vascular complication in the 30 days after surgery. In the study, half of 9,535 patients in 22 countries were randomly assigned TXA, half placebo. Patients were 45 years or older (average age 69 years); 44% of them were female.

Newswise: Researchers re-engineer red blood cells to trigger immune system against COVID-19
10-Mar-2022 10:00 AM EST
Researchers re-engineer red blood cells to trigger immune system against COVID-19
McMaster University

McMaster researchers have been able to re-engineer red blood cells and use them as a promising new vehicle for vaccine delivery.

Newswise: Better assessment of risk from heart surgery results in better patient outcomes
28-Feb-2022 8:05 AM EST
Better assessment of risk from heart surgery results in better patient outcomes
McMaster University

This study, published in the New England Journal of Medicine, assessed patients having heart surgery, measured troponin before and daily for the first few days after surgery, and assessed death and the incidence of major vascular complications – such as heart attack, stroke or life-threatening blood clot – after heart surgery. The study involved 15,984 adult patients with an average age just over 63 years undergoing cardiac surgery. Patients were from 12 countries, with more than a third of the countries being outside of North America and Europe.

Newswise: Now THAT's a wrap
Released: 28-Feb-2022 11:05 AM EST
Now THAT's a wrap
McMaster University

New research by the inventors of a promising pathogen-repellent wrap has confirmed that it sheds not only bacteria, as previously proven, but also viruses, boosting its potential usefulness for interrupting the transmission of infections.

Newswise: Scientists Discover How Caffeine Protects Against Cardiovascular Disease
Released: 9-Feb-2022 10:05 PM EST
Scientists Discover How Caffeine Protects Against Cardiovascular Disease
McMaster University

Scientists have a new understanding of the protective effects of caffeine on the cardiovascular system. While its stimulant effects have long been characterized, a team of McMaster University researchers have discovered how caffeine interacts with key cellular factors to remove cholesterol from the bloodstream.

Newswise: No needle required: Researchers confirm newly developed inhaled vaccine delivers broad protection against SARS-CoV-2, variants of concern
Released: 9-Feb-2022 6:05 AM EST
No needle required: Researchers confirm newly developed inhaled vaccine delivers broad protection against SARS-CoV-2, variants of concern
McMaster University

Scientists at McMaster University who have developed an inhaled form of COVID vaccine have confirmed it can provide broad, long-lasting protection against the original strain of SARS-CoV-2 and variants of concern. The research, recently published in the journal Cell, reveals the immune mechanisms and significant benefits of vaccines being delivered directly into the respiratory tract, rather than by traditional injection.

Newswise: Two for one: Repeated seasonal influenza vaccines also provide kids better protection against future flu pandemics, researchers find
1-Feb-2022 10:55 AM EST
Two for one: Repeated seasonal influenza vaccines also provide kids better protection against future flu pandemics, researchers find
McMaster University

Researchers at McMaster University have found that children who receive years of season-specific flu vaccines develop antibodies that also provide broader protection against new strains, including those capable of causing pandemics.

Newswise: Greater body fat a risk factor for reduced thinking and memory ability
Released: 1-Feb-2022 2:20 PM EST
Greater body fat a risk factor for reduced thinking and memory ability
McMaster University

A new study has found that greater body fat is a risk factor for reduced cognitive function, such as processing speed, in adults. Even when the researchers took cardiovascular risk factors (such as diabetes or high blood pressure) or vascular brain injury into account, the association between body fat and lower cognitive scores remained. This suggests other not yet confirmed pathways that linked excess body fat to reduced cognitive function.

Newswise: Changes in sleep and biological rhythms from late pregnancy to postpartum linked to depression and anxiety
Released: 18-Jan-2022 1:40 PM EST
Changes in sleep and biological rhythms from late pregnancy to postpartum linked to depression and anxiety
McMaster University

In the largest observational study to date investigating changes in sleep and biological rhythms during the peripartum period, researchers identified several variables that are linked to depression and anxiety. Most notably, changes in the circadian quotient (the strength of the circadian rhythms), the average amount of activity during nighttime rest, and the amount of fragmentation of nighttime rest were strongly linked to higher depressive and anxiety symptoms.Researchers recruited 100 women, 73 of whom they followed from the start of the third trimester to three months postpartum. They analyzed subjective and objective measures of sleep, biological rhythms, melatonin levels, and light exposure using a variety of tools, including questionnaires, actigraphs (wearable sleep monitors), laboratory assays, and other methods.

Released: 20-Dec-2021 9:40 AM EST
Researchers find oxytocin could be a potential treatment for some forms of autism
McMaster University

Oxytocin may be an effective treatment for some forms of autism, say McMaster researchers who have shown that in mice the hormone can correct patterns of brain activity associated with reduced social interest.

   
Released: 10-Dec-2021 12:00 AM EST
Toward more durable COVID vaccines
McMaster University

A new company spawned by McMaster University innovation in the arena of vaccine manufacturing has received a grant from the Bill & Melinda Gates Foundation. Elarex Inc., based in Burlington, has been awarded a $1.2M Cdn grant from the non-profit humanitarian foundation to develop a new technology for keeping liquid mRNA vaccines safe and viable without the deep-freeze that is necessary today for storing and transporting such vaccines.

Newswise: Ancient DNA found in soil samples reveals mammoths, Yukon wild horses survived thousands of years longer than believed
7-Dec-2021 10:45 AM EST
Ancient DNA found in soil samples reveals mammoths, Yukon wild horses survived thousands of years longer than believed
McMaster University

New research finds megafaunal collapse occurred before major environmental shift, small pockets of mammoths and horse adapted to change.

Released: 7-Dec-2021 9:00 AM EST
New study investigates immune response and vaccine hesitancy among First Nations communities
McMaster University

The study, called COVID CommUNITY- First Nations, will collect, analyze, and report data relating to COVID-19 vaccine effectiveness and safety, as well as explore hesitancy in three First Nations communities in Canada: Six Nations of the Grand River in southwestern Ontario; Lac La Ronge Indian Band in Saskatchewan; and Wendake in Quebec.

Released: 7-Dec-2021 8:45 AM EST
Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern
McMaster University

Human trials are set to begin for two next-generation COVID-19 vaccines developed by a team of scientists at McMaster University.

6-Dec-2021 4:30 PM EST
Researchers create contamination test for dairy products using technology that can be printed inside containers
McMaster University

Researchers have developed a test to reveal bacterial contamination in dairy products well before they have a chance to reach anyone’s lips. The concept is designed to be applied to any form of packaged food.

23-Nov-2021 4:20 PM EST
Pandemic depression persists among older adults: Study
McMaster University

Researchers used telephone and web survey data to examine how health-related factors and social determinants such as income and social participation, impacted the prevalence of depressive symptoms during the initial lockdown starting March 2020 and after re-opening following the first wave of COVID-19 in Canada. Caregiving responsibilities, separation from family, family conflict, and loneliness were associated with a greater likelihood of moderate or high levels of depressive symptoms that got worse over time.

Newswise: McMaster-led study links stress to Crohn’s disease flare-ups
16-Nov-2021 2:05 PM EST
McMaster-led study links stress to Crohn’s disease flare-ups
McMaster University

Using mouse models researchers found that stress hormones suppressed the innate immune system that normally protects the gut from invasive Enterobacteriaceae

Newswise: One in five vaccinated long-term care residents were at risk of COVID because of low antibody levels, supporting need for booster shots
Released: 16-Nov-2021 12:20 PM EST
One in five vaccinated long-term care residents were at risk of COVID because of low antibody levels, supporting need for booster shots
McMaster University

New research from McMaster University, aimed at understanding the immune response to COVID-19 vaccines, found some long-term care residents no longer had high antibody levels months after their second dose, directly supporting government decisions to provide third doses.

11-Nov-2021 1:55 PM EST
Milvexian an effective and safe oral pill for prevention of venous blood clots, says study
McMaster University

Researchers compared milvexian with enoxaparin for prevention of blood clots in 1,242 patients from18 countries undergoing knee replacement surgery who were enrolled between June 2019 and February 2021.They found that at a total daily dose of 100 mg or more, milvexian resulted in better clot protection but no increase in bleeding compared with enoxaparin, the control drug. Milvexian was evaluated in daily doses ranging from 25 to 400 mg; there was no increase in bleeding over this wide range of doses.

Newswise: McMaster scientists pinpoint key trigger of Crohn’s disease
1-Nov-2021 1:35 PM EDT
McMaster scientists pinpoint key trigger of Crohn’s disease
McMaster University

Researchers gleaned their results by analyzing blood and biopsy samples from two groups totalling 18 people with Crohn’s disease, comparing them to a matching number of people from two healthy control groups. A mouse model of IBD was also used. Khan said his study was the first demonstration of the interaction between serotonin, autophagy and gut microbiota in intestinal inflammation. The paper was published by Science Advances today. Sabah Haq, a PhD student who works with Khan, is first author.

3-Nov-2021 12:00 PM EDT
Study finds alcohol and cannabis sales rose with pandemic
McMaster University

The study used information from Statistics Canada to compare 16 months of alcohol and cannabis sales before and after the pandemic began (November 2018 to February 2020 compared to March 2020 to June 2021). During the pandemic period, Canadians bought 1.86 billion dollars more alcohol than was predicted based on the pre-pandemic trend. Increases in cannabis sales were $811 million higher, nearly a billion dollars above the predicted amount.

Newswise: An old drug saves lives of COVID-19 patients
26-Oct-2021 5:25 PM EDT
An old drug saves lives of COVID-19 patients
McMaster University

McMaster researcher Edward Mills and his team treated 739 randomly selected Brazilian COVID-19 patients with fluvoxamine, with another 733 receiving a placebo, between Jan. 15 to Aug. 6 of this year. Every patient who received fluvoxamine during the trial was tracked for 28 days to determine their health outcomes and if they still need hospital treatment. Researchers found about a 30 per cent reduction in hospitalizations among those receiving fluvoxamine compared to those receiving the placebo.



close
0.25614